AstraZeneca approached Gilead about potential merger – Bloomberg News

(Reuters) – AstraZeneca Plc (AZN.L) has approached rival drugmaker Gilead Sciences Inc (GILD.O) about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter.

AstraZeneca contacted Gilead last month and it did not provide terms of any transaction, the report bloom.bg/3h2GU9e added.

The two companies were not immediately available for comment.

Source: Read Full Article